Fulgent Genetics, Inc.
FLGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $283,470 | $289,213 | $618,968 | $992,584 |
| % Growth | -2% | -53.3% | -37.6% | – |
| Cost of Goods Sold | $176,255 | $184,757 | $252,067 | $215,533 |
| Gross Profit | $107,215 | $104,456 | $366,901 | $777,051 |
| % Margin | 37.8% | 36.1% | 59.3% | 78.3% |
| R&D Expenses | $48,816 | $41,440 | $28,910 | $24,219 |
| G&A Expenses | $88,106 | $88,999 | $111,074 | $50,732 |
| SG&A Expenses | $124,352 | $130,466 | $149,992 | $75,171 |
| Sales & Mktg Exp. | $36,246 | $41,467 | $38,918 | $24,439 |
| Other Operating Expenses | $7,965 | $128,079 | $9,472 | $1,708 |
| Operating Expenses | $181,133 | $299,985 | $188,374 | $101,098 |
| Operating Income | -$73,918 | -$195,529 | $178,527 | $675,953 |
| % Margin | -26.1% | -67.6% | 28.8% | 68.1% |
| Other Income/Exp. Net | $21,962 | $21,444 | $5,498 | $5,081 |
| Pre-Tax Income | -$51,956 | -$174,085 | $184,025 | $681,034 |
| Tax Expense | -$8,136 | $1,154 | $42,102 | $174,795 |
| Net Income | -$42,708 | -$167,825 | $143,403 | $507,364 |
| % Margin | -15.1% | -58% | 23.2% | 51.1% |
| EPS | -1.41 | -5.63 | 4.76 | 17.13 |
| % Growth | 75% | -218.3% | -72.2% | – |
| EPS Diluted | -1.41 | -5.63 | 4.63 | 16.26 |
| Weighted Avg Shares Out | 30,235 | 29,784 | 30,097 | 29,408 |
| Weighted Avg Shares Out Dil | 30,235 | 29,784 | 30,964 | 30,976 |
| Supplemental Information | – | – | – | – |
| Interest Income | $31,304 | $21,612 | $5,624 | $1,347 |
| Interest Expense | $170 | $488 | $1,013 | $0 |
| Depreciation & Amortization | $24,928 | $26,143 | $32,662 | $11,004 |
| EBITDA | -$48,990 | -$147,454 | $217,700 | $686,957 |
| % Margin | -17.3% | -51% | 35.2% | 69.2% |